PharmEasy gets $300 million booster shot for Thyrocare deal
US private equity major TPG, Singapores Temasek, Facebook cofounder Eduardo Saverins B Capital, Prosus (previously Naspers) and Think Investments participated in the funding round along with a new investor — Kotak Groups private equity arm, according to Siddharth Shah, chief executive of API Holdings, the parent company of PharmEasy.
via Economictimes
Post a Comment